Newron Pharmaceuticals SpA historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2022-09-23 | 1.330 | 1.330 | 1.220 | 1.330 | 1.330 | 186 |
| 2022-09-22 | 1.210 | 1.335 | 1.210 | 1.210 | 1.210 | 8,366 |
| 2022-09-21 | 1.320 | 1.340 | 1.200 | 1.340 | 1.340 | 24,626 |
| 2022-09-20 | 1.385 | 1.400 | 1.320 | 1.350 | 1.350 | 5,858 |
| 2022-09-19 | 1.340 | 1.365 | 1.340 | 1.360 | 1.360 | 4,202 |
| 2022-09-16 | 1.370 | 1.430 | 1.340 | 1.430 | 1.430 | 30,785 |
| 2022-09-15 | 1.370 | 1.430 | 1.370 | 1.430 | 1.430 | 1,823 |
| 2022-09-14 | 1.435 | 1.440 | 1.345 | 1.430 | 1.430 | 4,361 |
| 2022-09-13 | 1.435 | 1.440 | 1.335 | 1.440 | 1.440 | 5,315 |
| 2022-09-12 | 1.430 | 1.440 | 1.400 | 1.440 | 1.440 | 10,144 |
| 2022-09-09 | 1.370 | 1.380 | 1.370 | 1.380 | 1.380 | 873 |
| 2022-09-08 | 1.400 | 1.400 | 1.370 | 1.400 | 1.400 | 6,299 |
| 2022-09-07 | 1.435 | 1.435 | 1.400 | 1.400 | 1.400 | 1,043 |
| 2022-09-06 | 1.400 | 1.440 | 1.400 | 1.440 | 1.440 | 8,828 |
| 2022-09-05 | 1.400 | 1.400 | 1.340 | 1.400 | 1.400 | 13,103 |
| 2022-09-02 | 1.380 | 1.435 | 1.380 | 1.420 | 1.420 | 5,910 |
| 2022-09-01 | 1.380 | 1.380 | 1.380 | 1.380 | 1.380 | 765 |
| 2022-08-31 | 1.380 | 1.440 | 1.380 | 1.440 | 1.440 | 10,611 |
| 2022-08-30 | 1.435 | 1.440 | 1.435 | 1.440 | 1.440 | 1,951 |
| 2022-08-26 | 1.390 | 1.440 | 1.380 | 1.440 | 1.440 | 2,824 |
| 2022-08-25 | 1.380 | 1.430 | 1.380 | 1.430 | 1.430 | 92 |
| 2022-08-24 | 1.400 | 1.440 | 1.360 | 1.440 | 1.440 | 7,868 |
| 2022-08-23 | 1.375 | 1.420 | 1.375 | 1.420 | 1.420 | 8,106 |
| 2022-08-22 | 1.370 | 1.430 | 1.370 | 1.430 | 1.430 | 252 |
| 2022-08-19 | 1.450 | 1.450 | 1.370 | 1.440 | 1.440 | 601 |
| 2022-08-18 | 1.450 | 1.450 | 1.425 | 1.450 | 1.450 | 257 |
| 2022-08-17 | 1.400 | 1.400 | 1.360 | 1.400 | 1.400 | 3,251 |
| 2022-08-16 | 1.460 | 1.460 | 1.450 | 1.460 | 1.460 | 4,801 |
| 2022-08-15 | 1.370 | 1.450 | 1.360 | 1.450 | 1.450 | 12,592 |
| 2022-08-12 | 1.370 | 1.440 | 1.370 | 1.440 | 1.440 | 216 |
| 2022-08-11 | 1.370 | 1.440 | 1.370 | 1.440 | 1.440 | 233 |
| 2022-08-10 | 1.415 | 1.420 | 1.380 | 1.420 | 1.420 | 3,347 |
| 2022-08-09 | 1.380 | 1.380 | 1.380 | 1.380 | 1.380 | 5,124 |
| 2022-08-08 | 1.380 | 1.445 | 1.380 | 1.420 | 1.420 | 4,469 |
| 2022-08-05 | 1.375 | 1.450 | 1.370 | 1.450 | 1.450 | 1,213 |
| 2022-08-04 | 1.440 | 1.440 | 1.365 | 1.380 | 1.380 | 888 |
| 2022-08-03 | 1.400 | 1.400 | 1.370 | 1.400 | 1.400 | 3,000 |
| 2022-08-02 | 1.370 | 1.460 | 1.370 | 1.460 | 1.460 | 5,349 |
| 2022-07-29 | 1.435 | 1.450 | 1.370 | 1.430 | 1.430 | 5,790 |
| 2022-07-28 | 1.435 | 1.450 | 1.400 | 1.440 | 1.440 | 17,628 |
| 2022-07-27 | 1.445 | 1.445 | 1.350 | 1.440 | 1.440 | 8,641 |
| 2022-07-26 | 1.380 | 1.440 | 1.380 | 1.440 | 1.440 | 564 |
| 2022-07-25 | 1.400 | 1.435 | 1.370 | 1.400 | 1.400 | 1,677 |
| 2022-07-22 | 1.380 | 1.440 | 1.370 | 1.440 | 1.440 | 2,968 |
| 2022-07-21 | 1.400 | 1.470 | 1.380 | 1.470 | 1.470 | 3,945 |
| 2022-07-20 | 1.390 | 1.475 | 1.380 | 1.470 | 1.470 | 3,640 |
| 2022-07-19 | 1.370 | 1.450 | 1.370 | 1.390 | 1.390 | 9,136 |
| 2022-07-18 | 1.380 | 1.430 | 1.370 | 1.430 | 1.430 | 3,320 |
| 2022-07-15 | 1.445 | 1.450 | 1.370 | 1.380 | 1.380 | 15,140 |
| 2022-07-14 | 1.445 | 1.445 | 1.380 | 1.445 | 1.445 | 10,336 |
| 2022-07-12 | 1.380 | 1.450 | 1.370 | 1.450 | 1.450 | 2,138 |
| 2022-07-11 | 1.400 | 1.475 | 1.380 | 1.450 | 1.450 | 3,571 |
| 2022-07-08 | 1.370 | 1.485 | 1.370 | 1.485 | 1.485 | 12,762 |
| 2022-07-07 | 1.460 | 1.500 | 1.395 | 1.450 | 1.450 | 15,582 |
| 2022-07-06 | 1.510 | 1.510 | 1.410 | 1.490 | 1.490 | 7,129 |
| 2022-07-05 | 1.450 | 1.450 | 1.390 | 1.400 | 1.400 | 5,675 |
| 2022-07-04 | 1.400 | 1.500 | 1.400 | 1.500 | 1.500 | 778 |
| 2022-07-01 | 1.540 | 1.540 | 1.450 | 1.450 | 1.450 | 2,126 |
| 2022-06-30 | 1.450 | 1.545 | 1.400 | 1.530 | 1.530 | 4,285 |
| 2022-06-29 | 1.500 | 1.500 | 1.450 | 1.500 | 1.500 | 1,998 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (CHF). Adjusted close accounts for splits and dividends. Educational only, not financial advice.